Form 8-K/A BIOMARIN PHARMACEUTICAL For: Apr 27
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/15/2026
- Wall St ends higher on cool inflation data, strong earnings
- U.S. headline producer inflation posts first one-month decrease since August 2025
- PayPal rallies 20% on report Stripe, Advent made $53 billion bid
- Oil prices make small gain on smaller US inventory draw
- ASML capacity upgrade soothes AI chip bottleneck fears
BioMarin completes acquisition of Amicus Therapeutics
July 13, 2026 4:15 PM EDTBioMarin Pharmaceutical Inc. (NASDAQ: BMRN) has completed its acquisition of Amicus Therapeutics, Inc., according to a filing with the U.S. Securities and Exchange Commission.
BioMarin filed a Current Report on Form 8-K on April 27, 2026, disclosing the consummation of the deal. Under the terms... More
